title: Are bidentate ligands really better than monodentate ligands for nanoparticles?
abstract: Coordinating ligands are widely used to vary the solubility and reactivity of nanoparticles for subsequent bioconjugation. Although long-term colloidal stability is enhanced by using bidentate coordinating ligands over monodentate ones, other properties such as nonspecific adsorption of target molecules and ligand exchange have not been quantified. In this study, we modified a near-infrared dye to serve as a highly sensitive reporter for nonspecific binding of thiolated target molecules to nanoparticle surfaces that are functionalized with monodentate or bidentate coordinated ligands. Specifically, we analyzed nonspecific binding mechanisms to quantum dots (QDs) by fitting the adsorption profiles to the Hill equation and the parameters are used to provide a microscopic picture of how ligand density and lability control nonspecific adsorption. Surprisingly, bidentate ligands are worse at inhibiting adsorption to QD surfaces at low target/QD ratios, although they become better as the ratio increases, but only if the nanoparticle surface area is large enough to overcome steric effects. This result highlights that a balance between ligand density and lability depends on the dentate nature of the ligands and controls how molecules in solution can coordinate to the nanoparticle surface. These results will have major implications for a range of applications in nanobiomedicine, bioconjugation, single molecule spectroscopy, self-assembly, and nano(photo)catalysis where both nonspecific and specific surface interactions play important roles. As an example, we tested the ability of monodentate and bidentate functionalized nanoparticles to resist nonspecific adsorption of IgG antibodies that contained free thiol groups at a 1:1 QD/IgG ratio and found that QDs with monodentate ligands did indeed result in lower nonspecific adsorption.
authors.affiliation: Department of Chemistry and Biochemistry, University of Arkansas , 345 N. Campus Drive, Fayetteville, Arkansas 72701, United States.
authors.forename: Hiroko
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Benard
authors.initials: B
authors.lastname: Omogo
authors.forename: Colin D
authors.initials: CD
authors.lastname: Heyes
mesh_terms: D000327:Adsorption; D000906:Antibodies / Q000737:chemistry / Q000276:immunology; D007074:Immunoglobulin G / Q000737:chemistry / Q000276:immunology; D008024:Ligands; D053768:Metal Nanoparticles / Q000737:chemistry*; D036103:Nanotechnology; D045663:Quantum Dots / Q000737:chemistry*; D012995:Solubility; D013438:Sulfhydryl Compounds / Q000737:chemistry
chemical_list: D000906:Antibodies; D007074:Immunoglobulin G; D008024:Ligands; D013438:Sulfhydryl Compounds
references.citation: Science. 2005 Jan 28;307(5709):538-44
references.pmid: 15681376
references.citation: Fundam Clin Pharmacol. 2008 Dec;22(6):633-48
references.pmid: 19049668
references.citation: Nanotechnology. 2008 Jan 23;19(3):035701
references.pmid: 21817586
references.citation: Nat Protoc. 2006;1(3):1258-66
references.pmid: 17406409
references.citation: Nat Biotechnol. 2004 Jan;22(1):47-52
references.pmid: 14704706
references.citation: Science. 1998 Sep 25;281(5385):2016-8
references.pmid: 9748158
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15471-6
references.pmid: 16221762
references.citation: FASEB J. 1997 Sep;11(11):835-41
references.pmid: 9285481
references.citation: Science. 1998 Sep 25;281(5385):2013-6
references.pmid: 9748157
references.citation: Sensors (Basel). 2011;11(12):11036-55
references.pmid: 22247651
references.citation: J Am Chem Soc. 2005 Mar 23;127(11):3870-8
references.pmid: 15771523
references.citation: ACS Nano. 2008 Jul;2(7):1341-52
references.pmid: 19206301
references.citation: J Am Chem Soc. 2001 Sep 12;123(36):8844-50
references.pmid: 11535092
references.citation: Science. 2002 Nov 29;298(5599):1759-62
references.pmid: 12459582
references.citation: Biochem Biophys Res Commun. 2006 Sep 29;348(3):781-6
references.pmid: 16904647
references.citation: Nat Biotechnol. 2003 Jan;21(1):41-6
references.pmid: 12459735
references.citation: J Am Chem Soc. 2005 Apr 6;127(13):4556-7
references.pmid: 15796504
references.citation: Analyst. 2010 Jun;135(6):1395-9
references.pmid: 20407686
references.citation: J Am Chem Soc. 2004 May 19;126(19):6115-23
references.pmid: 15137777
references.citation: ACS Nano. 2009 Sep 22;3(9):2573-80
references.pmid: 19719085
references.citation: J Phys Chem C Nanomater Interfaces. 2013 Feb 7;117(5):2317-2327
references.pmid: 23543893
references.citation: Nat Biotechnol. 2004 Aug;22(8):969-76
references.pmid: 15258594